Indeed, it has been shown that GDF15 exhibited higher expression levels in secondary and lower expression in primary brain tumors, while its role in brain tumor progression was found to be inconsistent acting in a cell type- and context-dependent manner (18, 19, 21–23). The gene discussed is GDF15; the disease is brain neoplasm.